Seely Lynn sold LYEL
November 10, 2026 · Form 4 insider transaction
Seely Lynn sold 545 shares of Lyell Immunopharma, Inc. at $15.93 per share, a transaction worth $8.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
545
Price
$15.93
Total value
$8.7K
InsiderSeely Lynn
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 10, 2026
Filing dateNovember 12, 2026
Shares owned after63,354
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.